GE Healthcare Life Sciences is building a new 7,360 square meter facility in Grens, Switzerland, in the new Signy Park, for the manufacture of single use kits for the Sepax and Sefia cell processing systems. The facility will meet global regulatory requirements and is expected to be fully operational in 2022.
Argonaut Manufacturing Services, a premier contract development and manufacturing organization (CDMO) for biopharma, has announced the recent launch of their state-of-the-art aseptic vial filling services. Designed to maximize yield of expensive biologics and other high value drug substances, the custom Bausch + Ströbel VarioSys® line is the most advanced of its kind.
SAB Biotherapeutics (SAB), a clinical-stage biopharmaceutical development company advancing a new class of immunotherapies, today announced that it has entered into multiple collaboration and option agreements with global biotherapeutics leader CSL Behring.
STA Pharmaceutical Co., Ltd., (WuXi STA) – a subsidiary of WuXi AppTec – today announced the opening of its large-scale oligonucleotide active pharmaceutical ingredient (API) manufacturing facility in Changzhou, China
In a move to continue expanding our firm’s global presence—and to increase our proximity to key clients—ZS is excited to announce that three new offices will open their doors on Jan. 2, 2020: Seattle, Washington, D.C., and Cambridge, U.K.
Tessa Therapeutics (Tessa), a clinical-stage cell therapy company focused on the development of innovative cell therapies to treat cancer, today announced plans to open a 90,000 square foot commercial-scale cell therapy manufacturing facility in Singapore by end-2020, which will be one of the leading commercial-scale cell therapy manufacturing facilities in Asia.
UCB, a global biopharmaceutical company, today announced it will build an innovative and environmentally sustainable multi-product biological manufacturing facility on their site in Braine l’Alleud, Wallonia, Belgium.
ValGenesis, Inc., a market leader in Enterprise Validation Lifecycle Management Solutions (VLMS), today announced that a global biopharmaceutical company has chosen ValGenesis's 100% paperless VLMS to manage its corporate validation lifecycle process across multiple sites.